Safety and efficacy of chimeric antigen receptor T-cell therapy for acute myeloid leukemia: A subgroup based meta-analysis
<h3>Introduction</h3><p dir="ltr">Acute myeloid leukemia (AML) is a significant hematological malignancy in the United States, with a high mortality rate and limited treatment options. CAR T-cell therapy, a new and promising treatment, is being investigated for its effica...
محفوظ في:
| المؤلف الرئيسي: | Mahmoud M. Morsy (18560491) (author) |
|---|---|
| مؤلفون آخرون: | Ahmed Y. Azzam (14267391) (author), Osman Elamin (18560494) (author), Adam Elswedy (18560497) (author), Abdulqadir J. Nashwan (11659453) (author) |
| منشور في: |
2024
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Myelomastocytic transformation in chronic myeloid leukemia blast phase: A case report
حسب: Abdulrahman F. Al-Mashdali (17148316)
منشور في: (2025) -
Targeting human acute myeloid leukemia cells using human recombinant arginase I (Co) - PEG5000 [HuArgl (Co) - PEG5000] - induced arginine depletion. (c2013)
حسب: Tanios, Rita Farid
منشور في: (2013) -
Potency and selectivity of a urokinase activated recombinant anthrax toxin to acute myeloid leukemia (AML) cells. (c2015)
حسب: Darwich, Manal El.
منشور في: (2016) -
Dasatinib versus nilotinib as upfront therapy for treatment naïve chronic myeloid leukemia chronic phase
حسب: Mohamed A. Yassin (16322749)
منشور في: (2021) -
Safety and efficacy of tyrosine kinase inhibitors in pediatric chronic myeloid leukemia: A protocol for systematic review and meta-analysis
حسب: Fateen Ata (12217764)
منشور في: (2022)